| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratoire de Biotechnologie des Anticorps, Institut Curie, 75005 Paris [O. C., J-L., T.]; Gene Medicine Department, Rhône-Poulenc Rorer Central Research [M. K., I. D., M-C. M., F. S., B. T.], and Gencell, Centre de Recherche de Vitry Alfortville [A. V-O.], 94403 Vitry sur Seine; and Unité 255, Institut National de la Santé et de la Recherche Médicale, Institut Curie, 75005 Paris [W. H. F., J-L. T.], France
Mutated ras genes are found in a large number of human tumors and, therefore, constitute one of the primary targets for cancer treatment. Micro-injection of the neutralizing anti-Ras monoclonal antibody Y13-259 was previously reported to induce transient phenotypic reversion of ras-transformed rodent fibroblasts in vitro. We have prepared a single-chain Fv fragment (scFv) derived from Y13-259, and here, we show that intracellular expression of the scFv led to the specific inhibition of the Ras signaling pathway in Xenopus laevis oocytes and NIH3T3 fibroblasts. Moreover, neutralizing Ras with the scFv specifically promoted apoptosis in vitro in human cancer cells but not in untransformed cells. As a step toward cancer gene therapy, we finally demonstrated that intratumor transduction of HCT116 colon carcinoma cells with the anti-Ras scFv using an adenoviral vector elicited sustained tumor regression in nude mice.
1 This work was supported by the French Ministries of Industry and Research (Bio-Avenir Program) and by the Institut Curie.
2 To whom requests for reprints should be addressed, at Gene Medicine Department and Gencell, Centre de Recherche de Vitry Alfortville, 13 quai J. Guesde, 94403 Vitry sur Seine, France. Phone: 331 55 71 80 83; Fax: 331 55 71 37 96; E-mail: bruno.tocque@rhone-poulenc.com.
Received 9/ 2/97. Accepted 1/15/98.
This article has been cited by other articles:
![]() |
E. C. Stites and K. S. Ravichandran A Systems Perspective of Ras Signaling in Cancer Clin. Cancer Res., March 1, 2009; 15(5): 1510 - 1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moon, Y. Oh, and J. A. Roth Current Status of Gene Therapy for Lung Cancer and Head and Neck Cancer Clin. Cancer Res., November 1, 2003; 9(14): 5055 - 5067. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, G. T. Y. Chung, A. Forster, M. N. Lobato, and T. H. Rabbitts De novo production of diverse intracellular antibody libraries Nucleic Acids Res., March 1, 2003; 31(5): e23 - e23. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. d. Maur, C. Zahnd, F. Fischer, S. Spinelli, A. Honegger, C. Cambillau, D. Escher, A. Pluckthun, and A. Barberis Direct in Vivo Screening of Intrabody Libraries Constructed on a Highly Stable Single-chain Framework J. Biol. Chem., November 15, 2002; 277(47): 45075 - 45085. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Canevari, S. Biocca, and M. Figini Re: Blocking Oncogenic Ras Signaling for Cancer Therapy J Natl Cancer Inst, July 3, 2002; 94(13): 1031 - 1032. [Full Text] [PDF] |
||||
![]() |
J. S. Russell, U. Raju, G. J. Gumin, F. F. Lang, D. R. Wilson, T. Huet, and P. J. Tofilon Inhibition of Radiation-induced Nuclear Factor-{kappa}B Activation by an Anti-Ras Single-Chain Antibody Fragment: Lack of Involvement in Radiosensitization Cancer Res., April 1, 2002; 62(8): 2318 - 2326. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tse and T. H. Rabbitts Intracellular antibody-caspase-mediated cell killing: An approach for application in cancer therapy PNAS, October 24, 2000; 97(22): 12266 - 12271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Visintin, E. Tse, H. Axelson, T. H. Rabbitts, and A. Cattaneo Selection of antibodies for intracellular function using a two-hybrid in vivo system PNAS, October 12, 1999; 96(21): 11723 - 11728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Russell, F. F. Lang, T. Huet, M. Janicot, S. Chada, D. R. Wilson, and P. J. Tofilon Radiosensitization of Human Tumor Cell Lines Induced by the Adenovirus-mediated Expression of an Anti-Ras Single-Chain Antibody Fragment Cancer Res., October 1, 1999; 59(20): 5239 - 5244. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |